EP300 and neoplasm: An interesting thing to be mentioned here is the fusion event between ARHGEF17 and EP300. EP300—a histone acetyltransferase involved in the regulation of transcription via chromatin remodeling—has recently been revealed as a tumor suppressor modulating paclitaxel resistance and stemness against metastatic breast cancer [10].